当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:174.89亿  总市值:179.77亿
流通股本:15.56亿   总股本:15.99亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.04亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1094320.54万元,未分配利润317645.28万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1325186.49万元,负债230865.96万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,718,807,933.371,154,212,387462,257,650.832,821,441,302.71
营业总成本1,488,300,078.09975,738,044.24426,650,521.542,531,774,103.41
其他经营收益
营业利润140,353,629.7513,928,276.59-13,576,069.5296,674,057.99
利润总额136,278,616.6712,042,491.96-14,770,200.32184,502,101.62
净利润103,512,939.99-7,094,241.99-19,682,659.04174,397,875.24
每股收益
其他综合收益106,250,00039,950,000--45,900,000
综合收益总额209,762,939.9932,855,758.01-19,682,659.04128,497,875.24
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,912,282,709.356,727,743,135.546,748,867,229.37,066,828,580.51
非流动资产:
非流动资产合计7,339,582,207.347,274,758,697.417,615,216,822.157,657,483,328.74
资产总计13,251,864,916.6914,002,501,832.9514,364,084,051.4514,724,311,909.25
流动负债:
流动负债合计1,678,427,087.042,388,098,966.112,061,239,206.082,370,002,301.99
非流动负债:
非流动负债合计630,232,463.27848,104,682.44814,663,092.61846,445,195.46
负债合计2,308,659,550.313,236,203,648.552,875,902,298.693,216,447,497.45
所有者权益(或股东权益):
归属于母公司股东权益合计9,683,242,545.419,496,660,286.669,432,189,382.259,429,543,133.67
股东权益合计10,943,205,366.3810,766,298,184.411,488,181,752.7611,507,864,411.8
负债和股东权益合计13,251,864,916.6914,002,501,832.9514,364,084,051.4514,724,311,909.25
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,850,051,940.041,193,669,127.43461,359,189.823,597,730,735.8
经营活动现金流出小计1,770,359,850.281,077,012,043.08623,034,112.662,561,206,208.3
经营活动产生的现金流量净额79,692,089.76116,657,084.35-161,674,922.841,036,524,527.5
投资活动产生的现金流量:
投资活动现金流入小计161,922,690.01191,389827,6245,362,807.51
投资活动现金流出小计357,253,150.1141,478,824.7170,445,611.451,272,029,878.5
投资活动产生的现金流量净额-195,330,460.09-141,287,435.71-69,617,987.45-1,266,667,070.99
筹资活动产生的现金流量:
筹资活动现金流入小计2,440,0002,440,000-38,399,016.15
筹资活动现金流出小计1,969,865,412.911,204,374,595.6427,352,521.09409,429,658.57
筹资活动产生的现金流量净额-1,967,425,412.91-1,201,934,595.64-27,352,521.09-371,030,642.42
汇率变动对现金及现金等价物的影响908,358.771,233,445.5419,876.895,413,290.34
现金及现金等价物净增加额-2,082,155,424.47-1,225,331,501.46-258,625,554.49-595,759,895.57
期末现金及现金等价物余额1,676,947,391.542,533,771,314.553,500,477,261.523,759,102,816.01
补充资料:
现金及现金等价物的净增加额--1,225,331,501.46--595,759,895.57
TOP↑